Scott Cormack
2009
In 2009, Scott Cormack earned a total compensation of $816K as President and Chief Executive Officer at OncoGenex Pharmaceuticals, a 71% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $121,053 |
|---|---|
| Option Awards | $392,320 |
| Salary | $302,632 |
| Total | $816,004 |
Cormack received $392.3K in option awards, accounting for 48% of the total pay in 2009.
Cormack also received $121.1K in non-equity incentive plan and $302.6K in salary.
Rankings
In 2009, Scott Cormack's compensation ranked 5,111th out of 9,885 executives tracked by ExecPay. In other words, Cormack earned more than 48.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,111 out of 9,885 | 48th |
Division Manufacturing | 1,831 out of 3,690 | 50th |
Major group Chemicals And Allied Products | 374 out of 866 | 57th |
Industry group Drugs | 232 out of 638 | 64th |
Industry In Vitro and In Vivo Diagnostic Substances | 15 out of 44 | 66th |
Source: SEC filing on April 21, 2011.
Cormack's colleagues
We found two more compensation records of executives who worked with Scott Cormack at OncoGenex Pharmaceuticals in 2009.